{
    "nctId": "NCT02061527",
    "briefTitle": "Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment",
    "officialTitle": "Immediate Breast Reconstruction With or Without the Use of Acellular Dermal Matrix: A Randomized Controlled Multicenter Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 135,
    "primaryOutcomeMeasure": "The primary endpoint of this study is number of unplanned/ unanticipated surgical breast procedures. Other endpoints in the trial will be secondary.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient with invasive or pre-invasive (in situ) breast cancer, planned for immediate breast reconstruction post-skin sparing or nipple sparing mastectomy (unilateral or bilateral)\n* Patient agrees to participate in study and to sign an informed consent form\n* Able and willing to return for all scheduled and required study visits\n\nExclusion Criteria:\n\n* Is a smoker (patient having quit at least 4 weeks prior surgery can be included)\n* BMI \\<18 or \\> 30\n* Previous radiation therapy to the region at any time\n* Insulin-dependent diabetes or any immune deficiency requiring immunosuppressant use such as cortisone or biological therapies\n* Predicted implant size \\<200 or \\>600 ml per investigator assessment\n* Allergy to porcine\n* Pregnancy or lactating\n* Current enrollment or plans to enroll in another clinical trial unless a retrospective study\n* Neoadjuvant treatment with chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}